| 43.01 BATS BZX Real-Time Price As of 11:03am ET |  +0.87 / +2.06%Today’s Change | 34.32 Today|||52-Week Range 46.47 | -1.47% Year-to-Date |
| Previous close | 42.14 |
| Today’s open | 42.28 |
| Day’s range | 42.22 - 43.09 |
| Volume | 376,968 |
| Average volume (3 months) | 25,785,723 |
| Market cap | $245.8B |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -3.57% |
| Earnings growth (next 5 years) | +7.10% |
| Revenue growth (last year) | +2.10% |
| P/E ratio | 10.9 |
| Price/Sales | 4.86 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | +0.37 | +0.41% |
| MRKMerck | +0.77 | +0.96% |
| ABBVAbbVie | +0.74 | +0.94% |
| ABTAbbott Laboratories | +0.97 | +1.30% |
| Next reporting date | April 30, 2019 |
| EPS forecast (this quarter) | $0.75 |
| Annual revenue (last year) | $53.6B |
| Annual profit (last year) | -- |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Director, Chief Executive & Operating Officer Albert Bourla |
Chief Financial Officer & EVP-Business Operations Frank A. D'Amelio |
Corporate headquarters New York, New York |
